Tau kinases and phosphatases.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed.

1. Associations Between Diabetes Mellitus and Neurodegenerative Diseases.International journal of molecular sciences · 2025
   Review
2. Unraveling the complexity of human brain: Structure, function in healthy and disease states.Ageing research reviews · 2024
   Review
3. Nogo-A Drives Alzheimer's Disease Progression by Inducing Tauopathy Vulnerability.Aging and disease · 2024
   Article
4. Modulation of Tau Pathology in Alzheimer's Disease by Dietary Bioactive Compounds.International journal of molecular sciences · 2024
   Review
5. Comprehensive review on Alzheimer's disease: From the posttranslational modifications of Tau to corresponding treatments.Ibrain · 2024
   Review
6. Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies.International journal of molecular sciences · 2022
   Review
7. Type 2 Diabetes Mellitus Easily Develops into Alzheimer's Disease via Hyperglycemia and Insulin Resistance.Current medical science · 2021
   Review
8. Protective Effect of Natural Antioxidant, Curcumin Nanoparticles, and Zinc Oxide Nanoparticles against Type 2 Diabetes-Promoted Hippocampal Neurotoxicity in Rats.Pharmaceutics · 2021
   Article
9. The extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of Tau.Cell communication and signaling : CCS · 2021
   Article
10. Interactions and Cytotoxicity of Human Neurodegeneration- Associated Proteins Tau and α-Synuclein in the Simple ModelFrontiers in cell and developmental biology · 2021
    Article
11. Tau at the interface between neurodegeneration and neuroinflammation.Genes and immunity · 2020
    Review
12. Tau: It's Not What You Think.Trends in cell biology · 2019
    Review
13. It's all about tau.Progress in neurobiology · 2019
    Review
14. Untangling the Tauopathy for Alzheimer's disease and parkinsonism.Journal of biomedical science · 2018
    Review
15. Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits.Frontiers in neuroscience · 2018
    Review
16. ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins.Developmental dynamics : an official publication of the American Association of Anatomists · 2018
    Review
17. Expression of Tau Pathology-Related Proteins in Different Brain Regions: A Molecular Basis of Tau Pathogenesis.Frontiers in aging neuroscience · 2017
    Article
18. Tau protein modifications and interactions: their role in function and dysfunction.International journal of molecular sciences · 2014
    Review
19. Structure and pathology of tau protein in Alzheimer disease.International journal of Alzheimer's disease · 2012
    Article
20. Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis.Journal of cellular and molecular medicine · 2011
    Review

Corrections and comments

• Comment on
  Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as